iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | Sustainability & Chart
ISIN:
WKN:
IE00BDZVHG35
A2JDYM
ISIN:
IE00BDZVHG35
WKN:
A2JDYM
Basic information on the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Index
Nasdaq Biotechnology Index
Provider
iShares
Asset Class
Stocks
Total Expense Ratio (TER)
0,35%
Fund Volume
$ 415 million
Positions
265
Top 10 Weight
48,19%
Distribution Policy
Distributing
Replication Method
Physical
Launch Date
05.03.2018
Fund Currency
USD
As of: 07.05.2025
Overall Impact Performance
based on companies in this ETF
Climate
Society
Gender
Impact Score
Description iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) provides exposure to U.S. biotechnology companies, tracking the performance of the Nasdaq Biotechnology Index. The fund focuses primarily on firms involved in the research, development, and manufacturing of therapeutic treatments and pharmaceutical products.iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) Sustainability Performance
Climate
Society
Gender
Companies in this ETF are sustainable in this area.
Companies in this ETF are (not yet) sustainable in this area.
Companies in this ETF are not sustainable in this area.
No data available for companies in this ETF.
Renewable Energy
Greenhouse Gas Emissions
Supply Chain
Waste Recycling
Sustainable
(Not yet) sustainable
Not sustainable
No data
We measure the sustainability of the ETF based on the weighted average values of companies in the ETF. Each position is included in the overall assessment according to its share in the ETF. The ETF evaluation is based on 50.44% of the total ETF volume. In principle, equities and corporate bonds can be evaluated. Other asset classes or positions without available sustainability data were not taken into account. Learn more about our method.
Positions
Name | Weight | Country | Industry | Climate | Society | Gender | Impact Score |
|---|
Die größten 10 Positionen des iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) machen 48.19% des gesamten Fondsvolumens aus.
Stand: 07.05.2025
Compare iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) with ...
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
?
Impact Score
Climate
Society
Gender
Find more sustainable ETFs
© 2025 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.Logos provided by Clearbit (https://clearbit.com/). All trademarks and logos appearing on this website are the property of their respective owners and are used here for informational and educational purposes only, under fair use guidelines. We claim no affiliation with, nor endorsement by, the companies whose trademarks and logos are displayed. This website is independent of the brands analyzed and receives no direct or indirect compensation from them.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!